Cargando…
Long-term results on the suppression of secondary brain injury by early administered low-dose baclofen in a traumatic brain injury mouse model
Secondary injury from traumatic brain injury (TBI) perpetuates cerebral damages through varied ways. Attenuating neuroinflammation, which is a key feature of TBI, is important for long-term prognosis of its patients. Baclofen, a muscle relaxant, has shown promise in reducing excessive inflammation i...
Autores principales: | Park, Ji Young, Park, Junwon, Baek, Jiwon, Chang, Jin Woo, Kim, Young Goo, Chang, Won Seok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616194/ https://www.ncbi.nlm.nih.gov/pubmed/37903976 http://dx.doi.org/10.1038/s41598-023-45600-7 |
Ejemplares similares
-
Baclofen in the Therapeutic of Sequele of Traumatic Brain Injury: Spasticity
por: Pérez-Arredondo, Adán, et al.
Publicado: (2016) -
Outcomes of intrathecal baclofen therapy in patients with cerebral palsy and acquired brain injury
por: Yoon, Young Kwon, et al.
Publicado: (2017) -
Managing traumatic brain injury secondary to explosions
por: Burgess, Paula, et al.
Publicado: (2010) -
Traumatic Brain Injury and Secondary Neurodegenerative Disease
por: Dodd, William S., et al.
Publicado: (2022) -
Brain Phospholipid Precursors Administered Post-Injury Reduce Tissue Damage and Improve Neurological Outcome in Experimental Traumatic Brain Injury
por: Thau-Zuchman, Orli, et al.
Publicado: (2019)